Introduction {#Sec1}
============

Kashin-Beck disease (KBD) is an endemic and chronic osteoarthropathy which mostly occurs in children between the ages of 3 and 12 in Asia^[@CR1]^. The primary pathogenesis of KBD include chondrocyte degeneration, necrosis, progressive loss of articular cartilage and so on, which should result in arthrosis deformities in adult^[@CR2],[@CR3]^. In China, over 30 million people are at risk of KBD. There have been three etiological hypotheses of KBD, biology-earth-chemistry hypothesis (selenium deficiency), water organic compound poisoning hypothesis, and food fungi toxin poisoning hypothesis, but the accurate etiology of KBD is still unknown^[@CR4]--[@CR6]^.

Li *et al*. showed that low fluorine in the living environment caused an internal metabolic disorder, leading to pathological change of KBD^[@CR7]^. In addition, fluorosis and KBD are endemic diseases, which are closely associated with geology, geochemistry, hydrology and etc^[@CR8]^. Dental fluorosis (DF) is an early manifestation of fluorosis, which is caused by the excessive input of fluoride. There are three types of endemic fluorosis, including drinking-water type, coal-burning type and drinking-tea type. It was reported that water type fluorosis is the most common type in China, especially DF in children^[@CR9],[@CR10]^.

It has been reported that genetic factors play important roles in the pathogenesis of KBD and DF. Extensive genetic studies have been conducted to identify susceptibility genes for KBD and DF, and several valuable biomarkers have been obtained, such as HLA-DRB1, ITPR2, ADAM12, ameloblastin gene, and ER Rsa I. However, the mechanism of KBD and DF remains unclear. The variations of KBD and DF explained by the identified loci were limited, suggesting the existence of undiscovered genetic variants associated with KBD and DF.

The purpose of this study is to explore the common pathogenesis and the underlying molecular functions of KBD and DF. In this study, Affymetrix PrimeView™ Human Gene Expression Array was used for the quantification of genome-wide expression profiles from peripheral blood mononuclear cells of patients with KBD, KBD and DF, as well as healthy controls, for the comparative analysis. Functional enrichment analysis identified important processes related to the progression of KBD and DF. Several biomarkers were further confirmed by qRT-PCR. This should be helpful for the understanding of mechanisms of KBD and DF and the development of novel drugs and therapeutic methods.

Material and Methods {#Sec2}
====================

Study Population {#Sec3}
----------------

Study samples consists of 12 Han Chinese subjects, including 4 patients with KBD, 4 patients with DF and KBD and 4 healthy controls. Patients with KBD were diagnosed as grade II or grade III according to the clinical criteria (diagnostic code GB16395-1996). Donors of dental fluorosis were diagnosed with the modified Dean classification, which is national diagnosis standard and experimental test for fluoride (WS/T 208--2011). The subjects with osteoarthritis (OA), Rheumatoid arthritis (RA) and other skeletal diseases were excluded. All subjects were matched based on age and gender. This study was approved by Qinghai Institute for Endemic Disease Prevention and Control and Medical ethics committee of Qinghai Institute for Endemic Disease Prevention and Control. All participants signed inform-consent documents. This study was carried by *Qinghai provincial health and Family Planning Commission of science and Technology Education Department memo (2008) No. 6*.

RNA Extraction {#Sec4}
--------------

The peripheral blood were collected and stored at −80 °C. Blood samples needed to thaw at room temperature for 2 hours before RNA extraction. Total RNA was extracted with Agilent Total RNA Isolation Mini kit (Agilent Technologies, Santa Clara, CA) following the manufacturer's instructions. The RNA amount was normalized using The Human-Actin Competitive PCR Set (Takara Bio, Kyoto, Japan). To check the integrity of the total RNA, 60 ng (normalized value) denatured total RNA was subjected to 1% agarose gel electrophoresis, and dyed with ethidium bromide. Extracted RNA was stored at −80 °C until cDNA synthesis.

Microarray Hybridization {#Sec5}
------------------------

Total RNA was reverse-transcribed into complementary DNA (cDNA), and then transcribed into cRNA and labled with Cy-Dye using Amino Allyl MessageAmp aRNA Kit (Ambion) following the manufacturer's instructions. Thereafter, 0.5 μg of each labeled cRNA was purified separately and then mixed with hybridization buffer before being applied on the microarray. The hybridization solution was prepared with the *In Situ* Hybridization Plus kit (Agilent Technologies), and hybridization was performed in the hybridization chamber (Gene-Machines, San Carlos, CA, USA). Conditions of hybridization and washing were in accordance with the manufacturer's recommendations (Agilent Technologies).

Analysis of Microarray Data {#Sec6}
---------------------------

Affymetrix mRNA microarray were analyzed and transferred into CEL signal files using Affymetrix® GeneChip® Command Console® Software. A possible dye bias in the results was eliminated using an algorithm for the same extraction software (Extraction 9.3 Software, Agilent) that involves normalization factors (global normalization, location normalization). Normalized expression values was used for the identification of DEGs with limma package^[@CR11]^ of R based on the thresholds of fold change \>2 or \<0.5 and FDR adjusted p-value \< 0.05. For the exploration of processes involved in the development of KBD and DF, we also conducted functional enrichment analysis for DEGs through KOBAS^[@CR12]^ with the thresholds of p-value \< 0.05.

Quantitative Real-Time Reverse Transcription PCR {#Sec7}
------------------------------------------------

Total RNA was prepared for qRT-PCR. These RNA samples were transformed into complementary DNA (cDNA) using Superscript II reverse transcriptase (Invitrogen, Carlsbad, CA) and random primers. qRT-PCR was operated using the ABI 7500 Real-Time PCR system (Applied Biosys-tems, Foster City, CA) according to the manufacturer's specification.

To validate the microarray results, 8 significant differentially expressed genes were selected for parallel qRT-PCR analysis, including FCRL6, KLRC3, CXCR4, CD93, CLK1, GPR18, SRP1, KLRF1. Data were analyzed with the 2−ΔΔCt method using GAPDH as internal control.

Statistical analysis {#Sec8}
--------------------

R version3.2.2 was used for all of the statistical analysis. The relative mRNA level in the qPCR analysis was represented by mean ± SD of the three replicates, and p-value \< 0.05 was considered as statistical significant.

Results {#Sec9}
=======

Microarray Data Analysis {#Sec10}
------------------------

The GeneChip® PrimeView™ Human Gene Expression Array provides comprehensive coverage of the human genome in a cartridge array. Figure [1A](#Fig1){ref-type="fig"} illustrates the overall expression profiles in all samples. Comparable expression levels were obtained after normalization, which should be suitable for the following analysis. With the specified thresholds, 28 genes at higher level and 8 genes at lower level in KBD patients compared with controls were obtained. Tables [1](#Tab1){ref-type="table"} and [2](#Tab2){ref-type="table"} shows the up- and down-regulated genes and their enriched functions respectively. For patients with KBD and DF, we identified 11 up-regulated and 7 down-regulated genes compared with healthy controls. Tables [3](#Tab3){ref-type="table"} and [4](#Tab4){ref-type="table"} is the up- and down-regulated genes and their enriched functions respectively. Figure [1B,C](#Fig1){ref-type="fig"} illustrates the heatmap of DEGs in KBD patients and KBD and DF patients respectively in which green and red represents low and high expression level. A total of 10 overlaps, including 7 up-regulated (DUSP2, KLRF1, SRP19, KLRC3, CD69, SIK1 and ITGA4) and 3 down-regulated (ID3, HSPA1A and GPR18) genes, were identified between the two lists of DEGs. Strikingly, no gene was found to be significantly differential expression between patients with KBD and patients with DF.Figure 1Microarray analysis. (**A**) Relative mRNA level of all samples after normalization. White boxes are healthy controls, blue boxes are KBD samples and red boxes are KBD with DF samples. (**B**) Two-way hierarchical clustering of expression profiles and samples of healthy controls and KBD samples. (**C**) Two-way hierarchical clustering of expression profiles and samples of healthy controls and KBD with DF samples. Table 1List of genes differentially expressed in KBD \*(up-regulated genes).CategoryGene NamePublic IDGene SymbolFold ChangeapoptosisG0/G1 switch 2NM_015714G0S210.1038nuclear receptor subfamily 4, group A, member 2NM_006186NR4A23.9593salt-inducible kinase 1NM_173354SIK13.1203early growth response 1NM_001964EGR18.6298interleukin 6 signal transducerNM_001190981IL6ST2.1023metabolismchemokine (C-X-C motif) ligand 8NM_000584CXCL87.4122Kruppel-like factor 3 (basic)NM_016531KLF33.3914signal recognition particle 19 kDaNM_001204193SRP193.0827cysteine-serine-rich nuclear protein 1NM_033027CSRNP12.7026signal transductiondual specificity phosphatase 2NM_004418DUSP24.3656CD69 moleculeNM_001781CD693.1153killer cell lectin-like receptor subfamily C, member 3NM_002261KLRC32.5084eukaryotic translation initiation factor 4A2NM_001967EIF4A22.3559development corrlelatedintegrin, alpha 4NM_000885ITGA42.8429chemokine (C-X-C motif) receptor 4NM_001008540CXCR42.6099cystoskeleton and cell movementserine/threonine kinase 17bNM_004226STK17B2.5863WAS/WASL interacting protein family, member 1NM_001077269WIPF12.5435ectodermal-neural cortex 1 (with BTB domain)NM_001256574ENC12.0278bone resorptiontumor necrosis factor, alpha-induced protein 3NM_001270507TNFAIP32.5231membrane proteinkiller cell lectin-like receptor subfamily F, member 1NM_001291822KLRF12.4904CD160 moleculeNM_007053CD1602.2795claudin domain containing 1NM_001040181CLDND12.1154DNA modificationH3 histone, family 3ANM_002107H3F3A2.3112RNA processheterogeneous nuclear ribonucleoprotein D-likeNM_001207000HNRNPDL2.2607basic leucine zipper and W2 domains 1NM_001207067BZW12.039miscellaneousMIR22 host gene (non-protein coding)NM_032895MIR22HG2.2257DnaJ (Hsp40) homolog, subfamily B, member 1NM_006145DNAJB12.0591RNA binding motif protein 33NM_001008408RBM332.0549 Table 2List of genes differentially expressed in KBD \*(down-regulated genes).CategoryGene NamePublic IDGene SymbolFold Changemetabolismenhancer of polycomb homolog 2NM_015630EPC20.4687inhibitor of DNA binding 3NM_002167ID30.4964signal transductionG protein-coupled receptor 18NM_001098200GPR180.4933cystoskeleton and cellheat shock 70 kDa protein 1 ANM_005345HSPA1A0.4949movementformin 1NM_001103184FMN10.4882membrane proteinCD48 moleculeNM_001256030CD480.4984adrenoceptor beta 2NM_000024ADRB20.4836miscellaneoustumor necrosis factor, alpha-induced protein 8-like 2NM_024575TNFAIP8L20.4928 Table 3List of genes differentially expressed in KBD with DF (up-regulated genes).CategoryGene NamePublic IDGene SymbolFold Changedevelopment correlateddual specificity phosphatase 2NM_004418DUSP23.4894integrin, alpha 4NM_000885ITGA42.261menbrane proteinkiller cell lectin-like receptor subfamily F, member 1NM_001291822KLRF12.6744signal recognition particle 19 kDaNM_001204193SRP192.6216Fc receptor-like 6NM_001004310FCRL62.098signal transductionkiller cell lectin-like receptor subfamily C, member 3NM_002261KLRC32.639CD69 moleculeNM_001781CD692.4183salt-inducible kinase 1NM_173354SIK12.3002apoptosistumor necrosis factor, alpha-induced protein 3NM_001270507TNFAIP32.1203cystoskeleton and cell movementchemokine (C-X-C motif) receptor 4NM_001008540CXCR42.0905miscellaneousSH2 domain containing 1BNM_053282SH2D1B2.182 Table 4List of genes differentially expressed in KBD with DF (down-regulated genes).CategoryGene NamePublic IDGene SymbolFold Changedevelopment correlatedinhibitor of DNA binding 3NM_002167ID30.4673G protein-coupled receptor 18NM_001098200GPR180.3675menbrane proteinCD93 moleculeNM_012072CD930.4206cystoskeleton and cell movementnuclear mitotic apparatus protein 1NM_001286561NUMA10.1127metabolismheat shock 70 kDa protein 1 ANM_005345HSPA1A0.4804leucine rich repeat neuronal 3NM_001099658LRRN30.3146miscellaneousCDC-like kinase 1NM_001024646CLK10.4413

qRT-PCR Validation of Microarray Data {#Sec11}
-------------------------------------

8 genes were further verified by qRT-PCR. The results of qRT-PCR experiment were consistent with microarray analysis. According to qRT-PCR results, the expression levels of KLRC3, KLRF1, SRP19 and CXCR4 were higher in KBD and KBD with DF than controls, while expression levels of CLK1 and GPR18 were lower in both KBD and KBD with DF samples compared with healthy controls (shown in Fig. [2](#Fig2){ref-type="fig"}). Besides, FCRL6 was at higher level and CD93 was at lower level only in patients with KBD and DF.Figure 2Histogram showing the ratio of expression levels of the 8 selected genes in three groups, as analyzed by quantitative real-time reverse transcription--polymerase chain reaction (PCR) (n = 12). Bars show the standard deviations. (**A**), (**B**) and (**C**) is KBD samples, KBD with DF samples and healthy subjects respectively.

Discussion {#Sec12}
==========

KBD and DF are complex diseases that determined by genetic to a large extent. In this study, we conducted a comparative analysis of gene expression profiles for patients with KBD, KBD and DF, and healthy controls using Affymetrix PrimeView™ Human Gene Expression Array. qRT-PCR was used to validate the oligonucleotide array data. Based on the gene ontology enrichment analysis, we divided these genes into different categories, including metabolism, apoptosis, cytoskeleton, signal transduction and bone development-related genes. Cartilage damage is the main characteristics of pathological changes in KBD, including necrosis in deeper articular cartilage, excessive apoptosis of chondrocytes, extracellular matrix degradation and so on^[@CR13]--[@CR15]^. Endemic fluorosis is a chronic systemic diseases, characterized with lumbocrural pain, anchylosis, bone-deformity. It is necessary to study bone development-related genes of KBD and DF. Significant differences in gene expression pattern were observed between patients with KBD and healthy controls, as well as between patients with KBD and DF and healthy controls. Ten genes (7 up-regulated and 3 down-regulated) were found to be consistently differentially expressed in KBD and KBD with DF samples, which contains several bone development-related genes, such as DUSP2, ITGA4, ID3, GPR18, and they should provide valuable information for further understanding of KBD and DF.

In mammalian cells, the dual-specificity phosphatase (DUSP) family is responsible for the dephosphorylation of threonine and tyrosine residues. Hamamura *et al*. showed that Dusp2 could suppress inflammation in antibody-induced arthritis in a mouse model through down-regulating inflammatory signs^[@CR16]^. Besides, DUSP2 is involved in response to oxidative stress and apoptotic signaling, which play important roles in the development of KBD. Yin *et al*. reported that DUSP2 transcription was induced in response to oxidative stress, causing p53-dependent apoptosis^[@CR17]^. Moreover, DUSP2 involved in the process of salvianolic acid a (SAA) effects rat cardiomyocytes by mediating regulation of the ERK1/2/JNK pathway^[@CR18]^.

It was reported that the expression of integrin was associated with the osteoarthritis severity, especially ITGA4 (integrinα4). Becerril M *et al*. declared that ITGA4 played an important role in the loss of proteoglycans and clusters formation at OA early stages^[@CR19]^. Proteoglycans, the main component of extracellular matrix of cartilage, were associated with articular cartilage metabolism in patients with KBD^[@CR1],[@CR20]^. Consistent with the previous studies, we also identified ITGA4 as an important biomarker in the pathology of KBD.

Inhibitor of DNA Binding 3 (ID3), a transcription factor involved in the development of T cell and growth inhibition of a B cell progenitors, plays an important role in controlling cell cycle progression^[@CR21]--[@CR23]^. Thornemo *et al*. reported that ID3 is important for chondrocyte differentiation and ID proteins are expressed in a lot of cell types and decrease in various cell lines during differentiation^[@CR24]^. Here, ID3 was also proved to be down-regulated in KBD, as well as KBD and DF samples, which should indicate its roles in the progression of KBD and DF.GPR18, one of the orphan G protein-coupled receptors, has been found to be a receptor for endogenous lipid neurotransmitters. Ramos *et al*. reported that GPR18 was differentially expressed in osteoarthritis patients^[@CR25]^. Takenouchi *et al*. declared that GPR18 involved in the regulation of apoptosis^[@CR26]^, and apoptosis plays an important role on pathological process of KBD, so GPR18 might contribute the development of KBD.

In summary, we conducted a comparative analysis of gene expression profiles to explore the common pathogenesis and the underlying molecular functions between KBD and DF. Significant differences in gene expression pattern were found between KBD, KBD with DF samples and healthy controls. Our results should provide novel insights for further study of the molecular mechanism of KBD and DF. While, further studies should be conducted to confirm our findings.
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